Oligovax is an biopharmaceutical company focused on developing innovative therapies. The company's technology approach is based on drug substances consisting of synthetic oligonucleotides (ODNs) containing CpG motifs that have optimized immunostimulating properties. The CpG-ODN "Litenimod" developed by the company is a very powerful Th1 adjuvant when combined with a broad range of antigens, leading to both cytotoxic T lymphocytes (CTL) and antibody immune response.
Company Details
- Employees
- 2
- Founded
- 2000
- Address
- 102 Champs Elysées, Paris,ile De France 75008,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- oligovax.eu
- HQ
- Paris, Ile de France
Oligovax Questions
Oligovax's website is oligovax.eu
Oligovax's LinkedIn profile is https://fr.linkedin.com/company/oligovax
Oligovax has
2 employees.
View email and phone details for 2
employees at Oligovax.
Oligovax's industry is
Biotechnology Research
Oligovax's top competitors are
Redcat Biosciences,
Hempetik,
Purpl Research,
Icanc,
Thysun,
Everlux,
Exhalon,
Bioguess,
Med Sensors,
Biotypage.
Oligovax's categories are Biotechnology Research
Oligovax's founding year is 2000
